A randomized controlled trial of CAPEOX vs observation in patients with early-stage colorectal cancer with positive MRD after curative surgery (CAREME).

Authors

null

Ke-Feng Ding

Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Ke-Feng Ding , Qian Xiao , Jianbin Xiang , Yiming Zhou , Jun Song , Yixin Xu , Xue-Feng Huang , Min Chen , Jinlin Du , Ketao Jin , Xiaoyu Dai , Zhonglei Shen , Taiyuan Li , Shanping Ye , Wei Cui , Yibin Zhao , Wenbin Chen , Xiaofei Cheng , Haixing Ju , Qian Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05699746

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS225)

DOI

10.1200/JCO.2024.42.3_suppl.TPS225

Abstract #

TPS225

Poster Bd #

N13

Abstract Disclosures